| dc.contributor.author | Ezat, Beriwan Kassem Mohammed | |
| dc.date.accessioned | 2016-09-16T22:28:31Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | Ezat, Beriwan Kassem Mohammed. Geografiske forskjeller på fylkesnivå i avansert behandling av Parkinsons sykdom.. Master thesis, University of Oslo, 2016 | |
| dc.identifier.uri | http://hdl.handle.net/10852/52625 | |
| dc.description.abstract | | nob |
| dc.description.abstract | Absctract: Background: Parkinson´s disease is a neurodegenerative, chronic and progressive disease. In late stages, when per oral medication is not adequate to relive symptomes, advanced treatment should be consideres. Advanced therapy for Parkinson´s disease is Deep brain stimulation, Duodopa and Apomorphine. The aim of this project was to investigate geographical differences in deep brain stimulation and Duodopa for Parkinson´s disease patients. Methods: All 262 PD patients with initial startup of either deep brain stimulation or Duodopa in the periode 2009 – 2013, is included. | eng |
| dc.language.iso | nob | |
| dc.subject | | |
| dc.title | Geografiske forskjeller på fylkesnivå i avansert behandling av Parkinsons sykdom. | nob |
| dc.title.alternative | Geographical differences in advanced treatment for Parkinson´s disease. | eng |
| dc.type | Master thesis | |
| dc.date.updated | 2016-09-16T22:28:31Z | |
| dc.creator.author | Ezat, Beriwan Kassem Mohammed | |
| dc.date.embargoenddate | 3016-06-10 | |
| dc.rights.terms | Dette dokumentet er ikke elektronisk tilgjengelig etter ønske fra forfatter. Tilgangskode/Access code A | |
| dc.identifier.urn | URN:NBN:no-56015 | |
| dc.type.document | Prosjektoppgave | |
| dc.rights.accessrights | closedaccess | |
| dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/52625/1/Geografiske-forskjeller-p--fylkesniv--i-avansert-behandling-av-Parkinsons-sykdom-.pdf | |